Institutional investors purchased a net $606.9 thousand shares of MDCO during the quarter ended December 2013 and now own 101.90% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRONTIER CAPITAL MANAGEMENT CO. ... Bought 899.4 Thousand shares of Medicines Co
BRIDGER MANAGEMENT LLC Bought 630.0 Thousand shares of Medicines Co
NEUBERGER BERMAN LLC Bought 453.0 Thousand shares of Medicines Co